These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37231493)

  • 1. Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases.
    Sun M; Jiang W; Mu N; Zhang Z; Yu L; Ma H
    J Transl Med; 2023 May; 21(1):347. PubMed ID: 37231493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-based therapeutic strategies for mitochondrial dysfunction in cardiovascular disease.
    Suzuki I; Xing H; Giblin J; Ashraf A; Chung EJ
    J Biomed Mater Res A; 2024 Jun; 112(6):895-913. PubMed ID: 38217313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA Is a Vital Driving Force in Ischemia-Reperfusion Injury in Cardiovascular Diseases.
    Liu H; Liu X; Zhou J; Li T
    Oxid Med Cell Longev; 2022; 2022():6235747. PubMed ID: 35620580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies.
    Xia D; Liu Y; Wu P; Wei D
    Am J Pathol; 2023 Oct; 193(10):1485-1500. PubMed ID: 37481069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
    Todisco S; Musio B; Pesce V; Cavalluzzi MM; Petrosillo G; La Piana G; Sgobba MN; Schlosserová N; Cafferati Beltrame L; Di Lorenzo R; Tragni V; Marzulli D; Guerra L; De Grassi A; Gallo V; Volpicella M; Palese LL; Lentini G; Pierri CL
    Biochem Pharmacol; 2023 Feb; 208():115405. PubMed ID: 36603686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte death: mechanisms and translational implications.
    Chiong M; Wang ZV; Pedrozo Z; Cao DJ; Troncoso R; Ibacache M; Criollo A; Nemchenko A; Hill JA; Lavandero S
    Cell Death Dis; 2011 Dec; 2(12):e244. PubMed ID: 22190003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Exercise Training on Mitochondrial Function in Cardiovascular Diseases: A Systematic Review and Meta-Analysis.
    Lim AY; Chen YC; Hsu CC; Fu TC; Wang JS
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitophagy in cardiovascular disease.
    Zhou H; He L; Xu G; Chen L
    Clin Chim Acta; 2020 Aug; 507():210-218. PubMed ID: 32360616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mitochondrial dysfunction in cardiovascular disease: a brief review.
    Chistiakov DA; Shkurat TP; Melnichenko AA; Grechko AV; Orekhov AN
    Ann Med; 2018 Mar; 50(2):121-127. PubMed ID: 29237304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion Injury.
    Shin B; Cowan DB; Emani SM; Del Nido PJ; McCully JD
    Adv Exp Med Biol; 2017; 982():595-619. PubMed ID: 28551809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Updated Review of Mitochondrial Transplantation as a Potential Therapeutic Strategy Against Cerebral Ischemia and Cerebral Ischemia/Reperfusion Injury.
    Huang H; Oo TT; Apaijai N; Chattipakorn N; Chattipakorn SC
    Mol Neurobiol; 2023 Apr; 60(4):1865-1883. PubMed ID: 36595193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies.
    Huang Y; Zhou B
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Mitochondrial Drugs for Treatment of Ischemia-Reperfusion Injury.
    Peng JF; Salami OM; Habimana O; Xie YX; Yao H; Yi GH
    Curr Drug Targets; 2022; 23(16):1526-1536. PubMed ID: 36100990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies.
    Hayashida K; Takegawa R; Shoaib M; Aoki T; Choudhary RC; Kuschner CE; Nishikimi M; Miyara SJ; Rolston DM; Guevara S; Kim J; Shinozaki K; Molmenti EP; Becker LB
    J Transl Med; 2021 May; 19(1):214. PubMed ID: 34001191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases.
    Victor VM; Rocha M
    Curr Pharm Des; 2007; 13(8):845-63. PubMed ID: 17430185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 participates in the protective effect of exogenous mitochondria against mitochondrial dysfunction in myocardial ischaemic and hypoxic injury.
    Jia L; Yang L; Tian Y; Yang L; Wu D; Zhang H; Li M; Wu N
    Cell Signal; 2022 Apr; 92():110266. PubMed ID: 35091043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Mitochondrial DNA Copy Number With Cardiovascular Disease.
    Ashar FN; Zhang Y; Longchamps RJ; Lane J; Moes A; Grove ML; Mychaleckyj JC; Taylor KD; Coresh J; Rotter JI; Boerwinkle E; Pankratz N; Guallar E; Arking DE
    JAMA Cardiol; 2017 Nov; 2(11):1247-1255. PubMed ID: 29049454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer.
    Rocca C; Soda T; De Francesco EM; Fiorillo M; Moccia F; Viglietto G; Angelone T; Amodio N
    J Transl Med; 2023 Sep; 21(1):635. PubMed ID: 37726810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective.
    Zhou M; Yu Y; Luo X; Wang J; Lan X; Liu P; Feng Y; Jian W
    Cardiology; 2021; 146(6):781-792. PubMed ID: 34547747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial noncoding RNA-regulatory network in cardiovascular disease.
    Jusic A; Devaux Y;
    Basic Res Cardiol; 2020 Mar; 115(3):23. PubMed ID: 32140778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.